Stoke Therapeutics INC jobs

Director, Strategic Purchasing Bedford, Massachusetts, United States About Stoke: Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Using Stoke's proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke's first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke's initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke's proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/ Position Purpose: We are seeking a Strategic Purchasing Director. In this newly created position, you will lead Stoke's strategic sourcing and procurement function as we continue to grow into a later stage clinical development and potentially commercial biotechnology company. Reporting to the VP, Controller, you will have the opportunity to establish this critical function and build it as the company grows. A key component of this role is to build and manage long-term, mutually beneficial vendor relationships that drive value and support the company's mission to address the underlying cause of severe diseases. Additionally, you will act as a strategic partner with functional business partners across the company, in particular clinical development, clinical

Director, Financial Planning & Analysis (R&D) Bedford, Massachusetts, United States About Stoke: Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Using Stoke's proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke's first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke's initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke's proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/ Position Purpose: The Director, Financial Planning & Analysis (R&D) will play a critical role in financial and strategic decision making at the Company, playing a key role in the future growth of the organization. The focus of this position will be to provide overall financial business partnering to the Research & Development (R&D) functions including leading the budgeting, forecasting and long-range planning processes, supporting the monthly and quarterly close process, providing monthly reporting to department leads and the Executive Leadership Team, supporting external collaborations, and performing ad hoc financial analysis. This person will work closely with team members, department heads and program teams to understand and manage the performance of

Sr. Medical Director, Pharmacovigilance Bedford, Massachusetts, United States About Stoke: Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Using Stoke's proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke's first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke's initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke's proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/ Position Purpose: The Senior Medical Director, Pharmacovigilance will be responsible for the medical review of adverse event data, the development of company causality assessment frameworks in post-marketing surveillance, and leading signal detection and management activities. This individual will work in close partnership with PV operations to build rigorous, scalable, medical safety practices suited to a clinical development and complex postmarketing environment. This position will report into the Head of Pharmacovigilance. This is a role for a physician who is energized by developing business practice frameworks and review processes that a growing medical safety function requires and leading the medical safety domain within the organization. Rare disease carries meaningful responsibility to patient and

Associate Director, HCP Marketing Bedford, Massachusetts, United States About Stoke: Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Using Stoke's proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke's first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke's initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke's proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/ Position Purpose: The Associate Director, HCP Marketing will report to the Executive Director, Marketing. Along with the Executive Director of Marketing, you will be responsible for all HCP activities from disease education (DE) campaign development and deployment, as well as the creation of the branded campaign for the potential launch of zorevunersen. We are looking for someone with a particular expertise in non-personal marketing, but experience in others areas, such as KOL engagement, market research and congress strategy & execution, are a bonus. As a small company, we operate at a fast pace with many competing priorities so the ability to thrive in this type of requirement is essential. Key Responsibilities: Work

Senior Director, Clinical Quality Compliance Bedford, Massachusetts, United States About Stoke: Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Using Stoke's proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke's first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke's initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke's proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/ Position Purpose: The Sr. Director, Clinical Quality Compliance, will be responsible for overseeing all aspects of GCP and GCLP associated with the development, maintenance and oversight of activities related to Clinical Trials sponsored by Stoke. This role will report into The VP of Quality and will partner closely with other cross-functional groups such as Clinical Development, Clinical Development Operations, DMPK, Toxicology, Regulatory and other functions within Quality to embed GCP quality considerations into clinical development. This person will lead clinical quality strategy across Stoke's clinical programs. This role ensures global GCP and GCLP compliance (e.g., FDA, EMA, ICH etc.), provides guidance on clinical trial operations, and fosters a culture of quality,

Vice President, Field Leader, Market Access Field National & Regional Bedford, Massachusetts, United States About Stoke: Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Using Stoke's proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke's first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke's initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke's proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/ Position Purpose: The Executive Director/Vice President, Field Leader - Market Access Field National & Regional will be responsible for building and leading Stoke's market access organization, including Market Access Account Directors (MADs) and Field Reimbursement Managers (FRMs). This leader will develop and execute the field strategy to ensure broad, timely, and sustained access to Zorevunersen across payers and ensure provider sites are compliantly supported on reimbursement processes. The role will focus on establishing trusted relationships with national and regional payers, Commercial and Medicaid, along with healthcare providers to minimize barriers to patient access. As part of the Market Access leadership team, this individual will play a

Director/Senior Director, Global Medical Information & Operations Bedford, Massachusetts, United States About Stoke: Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Using Stoke's proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke's first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke's initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke's proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/ Position Purpose: Stoke Therapeutics is seeking an experienced and hands-on Medical Information leader to build, operationalize, and scale the Medical Information (MI) function in advance of commercialization. This role will have end-to-end ownership of Medical Information, including contact center strategy and operations, scientific response content, inquiry management, and development of a scalable, digitally enabled self-service medical information portal. This role requires strong operational rigor and a forward-looking mindset, with comfort working in ambiguity and establishing new ways of working. The ideal candidate brings a balance of scientific credibility, operational excellence, and curiosity about how Medical Information can continue to evolve in a growing organization. Key Responsibilities: Medical Information Strategy

Pharmacovigilance Scientist Bedford, Massachusetts, United States About Stoke: Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Using Stoke's proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke's first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke's initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke's proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/ Position Purpose: We are building our Pharmacovigilance department in support of ongoing clinical development activities and NDA submission for a first-in-class antisense oligonucleotide (ASO) therapy in a rare pediatric neurological disease. The PV Scientist is a newly created role and a genuine opportunity to shape the scientific infrastructure of PV department at a critical inflection point. The PV Scientist is accountable for overall PV science support for pharmacovigilance department at Stoke, which includes working in collaboration with the Safety Physician(s) and cross-functional teams to lead signal detection activities conducted in the safety governance model within the company. The ideal candidate will have deep PV science experience and will contribute across clinical and regulatory workstreams

Band 5 - Intensive Therapy Unit Nurse - Stoke-on-Trent Manchester

Band 5 - Chemotherapy Nurse - Stoke-on-Trent Stoke-on-Trent

VodafoneThree - Incident Specialist Stoke on Trent, United Kingdom | ST1 5GP | Stoke-on-Trent ST1 5GP, UK

Technical Writer Stoke on Trent posted: Posted 30+ Days Ago

Project Manager Stoke on Trent posted: Posted 15 Days Ago

Systems Test Engineer Stoke on Trent posted: Posted 30+ Days Ago

Occupational Hygiene & SHE Technician Stoke On Trent posted: Posted 24 Days Ago

Short-term Temporary Team Member - Stoke Talke Outlet (N119970) Stoke-On-Trent, Staffordshire, United Kingdom SHIFTS YOU ARE APPLYING FOR: 5.50hrs p/w; Sat 11:00 - 17:00

Short-term Temporary Team Member - Stoke Talke Outlet (N119974) Stoke-On-Trent, Staffordshire, United Kingdom SHIFTS YOU ARE APPLYING FOR: 5.50hrs p/w; Sat 09:00 - 15:00

Short-term Temporary Team Member - Stoke Talke Outlet (N119971) Stoke-On-Trent, Staffordshire, United Kingdom SHIFTS YOU ARE APPLYING FOR: 5.50hrs p/w; Sat 11:00 - 17:00

Short-term Temporary Team Member - Stoke Talke Outlet (N119973) Stoke-On-Trent, Staffordshire, United Kingdom SHIFTS YOU ARE APPLYING FOR: 5.50hrs p/w; Sat 09:00 - 15:00

Short-term Temporary Team Member - Stoke Talke Outlet (N119972) Stoke-On-Trent, Staffordshire, United Kingdom SHIFTS YOU ARE APPLYING FOR: 5.50hrs p/w; Sat 12:00 - 18:00

Beauty Advisor - Estee Lauder - M&S Wolstanton Wolstanton Stoke,GB-STE,United Kingdom

VodafoneThree - Account Manager, Multinational Customers Stoke on Trent, United Kingdom

Industrial Engineer Stoke On Trent posted: Posted 22 Days Ago

VodafoneThree - Business Development Specialist, MNC Stoke on Trent, United Kingdom